P3 Health Partners Inc.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$385M
↑+3.8% +$14Mvs FY2024 (Q4)
Gross Profit
$385M
↑+3.8% +$14Mvs FY2024 (Q4)
Operating Income
$364M
↑+4.2% +$15Mvs FY2024 (Q4)
Net Income
$362M
↑+5.3% +$18Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $385M | $371M |
| COGS | $0 | $0 |
| Gross Profit | $385M | $371M |
| R&D | $0 | $0 |
| SG&A | $0 | $0 |
| D&A | $21M | $21M |
| Other OpEx | $0 | $384K |
| Operating Income | $364M | $349M |
| Interest Exp. | $0 | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $364M | $349M |
| Tax | $1M | $5M |
| Net Income | $362M | $344M |
QuarterCharts · SEC EDGAR data · PIII · Comparing FY2025 (Q4) vs FY2024 (Q4)